baber/WOPTO huggingface dataset:
Patent AU-2021407925-A1 (AU)
Title: Simulated photographing special effect generation method and apparatus, device, and medium
Inventor: WANG YUJIA
IPC: G06F9/455
Filed: 2021-11-24
Abstract: Embodiments of the present disclosure relate to a simulated photographing special effect generation method, comprising: in response to a setting operation of a user on a special effect behavior event, adding a photographing behavior event; in response to a setting operation of the user on an image element associated with the photographing behavior event, determining an image element before photographing and/or an image element after photographing associated with the photographing behavior event; in response to a setting operation of the user on a trigger condition of the photographing behavior event, determining a trigger condition associated with the photographing behavior event; and storing the image element before photographing, the image element after photographing, and the photographing trigger condition which are associated with the photographing behavior event in association in a special effect configuration file. The present technical solution can meet the requirements of the user for making diversified special effects.
Patent AU-2021443688-A1 (AU)
Title: Battery including folded foil portion and method of fabricating same
Inventor: SUBRAMANIAN ADITYA
IPC: H01M4/04
Filed: 2021-04-29
Abstract: A battery includes an anode, a cathode, one or more separators, and an electrolyte. The anode, the cathode, the one or more separators, and the electrolyte are disposed in a roll configuration. At least one of the anode or the cathode includes a foil portion having a plurality of bent portions in different widths that are bent inwardly toward an axis of the roll configuration and that define an edge of the roll configuration.
Patent AU-2021453871-A1 (AU)
Title: Polymerase mutants and use with 3'-oh unblocked reversible terminators
Inventor: CAYOUETTE MICHELLE
IPC: C12N9/12
Filed: 2021-06-29
Abstract: Mutant polymerases are provided that have improved ability to incorporate modified nucleotides, including 3 '-OH unblocked reversible terminators. The mutant polymerases may be used in a variety of applications, such as for polynucleotide sequencing, primer extension reactions, and template-independent enzymatic oligonucleotide synthesis.
Patent WO-2023115117-A1 (WO)
Title: Extrudeuse à haute température pour imprimante 3d
Inventor: JAIN ASHISH
IPC: B29C64/209
Filed: 2022-12-19
Abstract: L'invention concerne une extrudeuse pour impression par FDM en 3D avec une buse en céramique hautement thermoconductrice qui permet un fonctionnement à très haute température approprié pour l'impression de métaux et de matières plastiques à haut point de fusion, tout en étant également résistante à l'usure pour faire face aux matériaux abrasifs. Un élément chauffant est imprimé sur la buse pour permettre d'obtenir des températures élevées dans un espace compact. Une jupe fixée à la buse assure le chauffage du matériau déjà déposé pour aider au collage du métal à mesure qu'il est déposé, ainsi qu'à l'extraction de fumées. Un tube de descente en céramique non-conductrice isole thermiquement la buse du mécanisme d'alimentation en matériau. Toutes les parties principales sont elles-mêmes imprimées en 3D.
Patent AU-2022204447-A1 (AU)
Title: DMLS orthopedic intramedullary device and method of manufacture
Inventor: FABER HENRY
IPC: B22F3/105
Filed: 2022-06-23
Abstract: An orthopedic device, such as an intramedullary nail, for internal fixation of a bone and a 
method of manufacturing the same. The orthopedic device may be formed from a medical 
grade powder via an additive manufacturing process. The forming process may include heat 
treating the additive manufactured component and machining the heat treated additive 
manufactured component to form the orthopedic device. Further, the orthopedic device may 
be formed to include an internal sensor probe channel that extends within at least a portion 
of the wall of the device, but which does not protrude through an outer portion of the wall.  
Embodiments further include a dynamizing intramedullary nail that accommodates 
adjustments in the relative axial positions of one or more sections of the orthopedic device.  
The device may include features in an inner region of the orthopedic device that may alter 
an elastic modulus of the orthopedic device.
Patent AU-2022215232-A1 (AU)
Title: Artificial intelligence and robotic process automation for automated data management
Inventor: DIWAN GAURAV
IPC: G10L15/18
Filed: 2022-08-11
Abstract: A computer-implemented method, including receiving, by a device, a user input, 
wherein the user input is received via a communication that is occurring in real time with a 
user, wherein the user input is received from a virtual assistant device, and wherein the 
communication is associated with an account of the user, identifying, by the device, a data 
management platform associated with the account, causing, by the device, a natural 
language processing model to analyze the user input, wherein the natural language 
processing model is configured to identify, from the user input, an operation associated with 
the account, the operation including one or more of creating the account, editing user 
information associated with the account, adding information to the account, removing 
information from the account, removing an association with the account, adding a service 
associated with the data management platform, or linking the account to another data 
management platform that is different from the data management platform, identifying, by 
the device, the operation that is to be performed, wherein the operation is to be performed 
according to the user input, and wherein the operation is to be performed in association with 
the account, determining, by the device, whether the operation can be performed using an 
application programming interface (API) enabling direct access to the data management 
platform, wherein determining whether the operation can be performed using the API 
includes determining whether the data management platform permits a backend service to 
be used to perform the operation, and determining whether the backend service is operable 
to perform the operation, the backend service determined not to be operable to perform the 
operation when one or more of the backend service is outdated, the backend service is 
corrupted, the backend service is unavailable, or the device is incompatible with the data 
management platform, and selectively causing, by the device, the operation to be performed 
on the data management platform using an API call when the operation is determined to be 
capable of being performed using the API enabling direct access to the data management 
platform, or a robotic process automation (RPA) when the operation is determined not to be 
capable of being performed using the API associated with the data management platform, 
the RPA using a user interface associated with the data management platform to perform 
the operation by identifying information in the user input that is to be used to update the 
account according to the operation, identifying the user interface associated with the data
management platform, identifying an element of the user interface that permits the account 
to be updated with the information according to the operation, and causing the element to 
update the account by automatically entering the information via the user interface.
Patent AU-2022220313-A1 (AU)
Title: Engineered extracellular vesicles and their uses
Inventor: LU BAISONG
IPC: A61K9/107
Filed: 2022-02-11
Abstract: Provided herein are compositions and methods for making extracellular vesicles. In some embodiments, the extracellular vesicles are used in methods for modifying cells and in methods for treating a disease in a subject.
Patent AU-2022228430-A1 (AU)
Title: Diazepine derivatives useful in the treatment of clostridium difficile
Inventor: GENIN MICHAEL JAMES
IPC: C07D401/14
Filed: 2022-03-01
Abstract: The present disclosure describes compounds of Formula (I) and Formula (II) and stereoisomers, tautomers, and pharmaceutically acceptable salts or solvates thereof, wherein all of the variables are as defined herein. This disclosure also relates to pharmaceutical compositions comprising these compounds and methods of treating a disease, disorder, or condition by using the compounds and pharmaceutical compositions.
Patent AU-2022230128-A1 (AU)
Title: Mechanical connection arrangement for panels
Inventor: SVENSSON JOHAN
IPC: A47B47/04
Filed: 2022-02-17
Abstract: A mechanical connection arrangement for panels (1, 2), comprises a first panel (1), a second panel (2) and a mechanical locking device for locking the first panel (1) to the second panel (2). A surface of the first panel (1) and a surface of the second panel (2) are parallel and in contact in a locked position of the first and second panels (1, 2). The mechanical locking device comprises at least one rod-shaped element (3) at said surface of the first panel (1) and at least one corresponding insertion recess (4) at said surface of the second panel (2). The rod-shaped element (3) is configured to be inserted in the insertion recess (4). The lateral surface of the rod-shaped element (3) extends at a first angle (α) from the surface of the first panel (1) and the lateral side of the insertion recess (4) extends into the second panel (2) at a second angle (β) from the surface of the second panel (2). The difference between the first angle (α) and the second angle (β) is between 0.5 and 6, 2 and 4, or about 3 in an unlocked position of the first and second panels (1, 2). The rod-shaped element (3) and the insertion recess (4) are configured such that the difference between the first angle (α) and the second angle (β) is smaller in the locked position compared to when in the unlocked position.
Patent AU-2022259798-A1 (AU)
Title: Gonioscopic devices
Inventor: KALINA JR CHARLES RAYMOND
IPC: A61B3/117
Filed: 2022-10-27
Abstract: A gonioscopic attachment can attach to a gonioscope and can include atraumatic retention 
elements that are configured to engage an eye to retain the gonioscope relative to the eye.  
The gonioscopic attachment can be configured to position the gonioscope so that at least a 
portion of the concave distal surface of the gonioscopic optical element is spaced apart from 
the eye, and/or so that the curvature of the distal surface is angularly offset from the curvature 
of the eye. The gonioscope can include a fixation point configured to be visible to the subject 
when the gonioscope is positioned on the eye. In some embodiments, the retention elements 
can be incorporated directly into the gonioscope. A coupling mechanism can couple the 
gonioscope to a lid speculum. The gonioscope can include a light pipe, which can be 
configured to directly light into the eye.  
-64-
Patent AU-2022260522-A1 (AU)
Title: Methods of treating b-cell lymphoma using combination therapy
Inventor: PATAH POLIANA
IPC: A61K31/475
Filed: 2022-04-20
Abstract: Provided herein are methods of using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-l-yl)methyl)benzyl)amino)isoindoline-l, 3-dione, or an enantiomer, a mixture of enantiomers, a tautomer, an isotopolog, or a pharmaceutically acceptable salt thereof, in combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone or an equivalent thereof for treating, preventing or managing B-cell lymphoma.
Patent AU-2022268290-A1 (AU)
Title: Method and system for enabling acquisition of borehole survey data and core orientation data
Inventor: MCLEOD GAVIN
IPC: E21B23/02
Filed: 2022-11-07
Abstract: A system (10) and method (50) of enabling the acquisition of borehole survey data and 
core orientation data in a single instrument trip in a core drill (12) having a drill string 
(18) and an inner core barrel assembly (16). The method uses a borehole survey tool 14 
that is arranged to at least log its position in three-dimensional space. The borehole 
survey tool (14) is run down the drill string (12) in which the inner core barrel 
assembly (16) is installed. The inner core barrel assembly (16) is arranged to either 
provide or facilitate detection of an indication of tool face of a core sample (24) held in 
the inner core barrel assembly (16). The indication of tool face is then transferred 
mechanically or electronically to the visiting borehole survey tool (14).
Patent AU-2022283289-A1 (AU)
Title: Methods of controlling cleavage of formylglycine-containing polypeptides
Inventor: Holder Patrick
IPC: A61K38/00
Filed: 2022-05-25
Abstract: Methods for reducing cleavage of a protein comprising a formylglycine (fGly) amino acid is provided. Such methods can involve protecting the protein from exposure to visible light having a wavelength of 500 nm or lower. Also provided herein are methods for inducing cleavage of a protein in a target region, the target region comprising an fGly amino acid. The methods may involve exposing the protein to visible light comprising a wavelength of 300 nm - 500 nm in the presence of a flavin. Cleavage of the protein may be carried out in the presence of a molecule that is photoactivated to release singlet oxygen species. Cleavage of the protein may be carried out in the presence of a flavin.
Patent AU-2022301303-A1 (AU)
Title: System and method for identifying when a water-sports participant has fallen
Inventor: UGGERI MICHAEL
IPC: B63B34/70
Filed: 2022-07-01
Abstract: A boat, boat systems, and methods to determine when a water-sports participant has fallen. The boat may include an image sensor and an image processor communicatively coupled to the image sensor. The image sensor is configured to capture at least one image of the environment aft of the stem of the boat. The image processor is configured to execute a rider-down analysis that includes analyzing, using an object recognition process executed by the image processor, an image to be analyzed to determine if a water-sports participant has fallen. The boat may include a controller configured to execute a rider-down action when the water-sports participant has fallen. The controller may execute the rider-down action when the image processor determines that the water-sports participant has fallen based upon the rider-down analysis.
Patent AU-2022315201-A1 (AU)
Title: Inhibitors targeting ubiquitin specific protease 7 (usp7)
Inventor: BUHRLAGE SARA
IPC: C07D401/06
Filed: 2022-07-20
Abstract: Disclosed herein are inhibitors of deubiquitinating (DUB) enzyme USP7 (Ubiquitin Specific Protease 7). Also provided are methods of treating a disease or disorder modulated by USP7.
Patent WO-2023225713-A1 (WO)
Title: Biomarqueurs pour l'immunothérapie allergénique
Inventor: VAN ZELM MENNO C
IPC: G01N33/50
Filed: 2023-05-24
Abstract: La présente invention concerne le domaine des diagnostics médicaux. En particulier, l'invention concerne des procédés et des kits pour déterminer l'efficacité de traitement d'une immunothérapie allergénique, et pour mesurer ou détecter des biomarqueurs chez un sujet soumis à une immunothérapie allergénique. Par exemple, l'invention concerne un procédé de détermination de l'efficacité d'une immunothérapie allergénique chez un sujet, le procédé comprenant : fournir un premier échantillon obtenu à partir d'un sujet avant de recevoir une immunothérapie allergénique ; fournir un second échantillon obtenu à partir du sujet qui a reçu, ou qui reçoit, une immunothérapie allergénique ; les premier et second échantillons comprenant des lymphocytes B ; et déterminer le niveau ou la quantité d'un ou de plusieurs biomarqueurs dans les lymphocytes B, de préférence les lymphocytes B spécifiques de l'allergène, dans les premier et second échantillons, les biomarqueurs étant choisis dans le groupe constitué par IgE, CD29, CD69, IL13Rα, CD99, IgD, CXCR4, FCRL3, FCRL2, FCRL5, SIGLEC10, CD1c, CD23 et IL4Rα ; une augmentation du niveau ou de la quantité d'un ou de plusieurs biomarqueurs choisis parmi IgE, CD29, IL13Rα, CD99, FCRL3, FCRL2, SIGLEC10, CD1c, CD23 et IL4Rα dans les lymphocytes B du second échantillon par rapport au premier échantillon indiquant l'efficacité d'une immunothérapie allergénique chez un sujet, et/ou une diminution du niveau ou de la quantité d'un ou de plusieurs biomarqueurs choisis parmi CD69, IgD, CXCR4, FCRL3, FCRL2, FCRL5, CD1c, CD23, IL4Rα dans les lymphocytes B du second échantillon par rapport au premier échantillon indiquant l'efficacité d'une immunothérapie allergénique chez un sujet.
Patent AU-2023263458-A1 (AU)
Title: Cable clamp for photovoltaic power plant
Inventor: DONGQUAN LIN
IPC: H02G3/32
Filed: 2023-11-07
Abstract: A cable clamp for a photovoltaic power plant, comprising an upper clamp plate, a middle plate, 
and a lower clamp plate arranged successively from top to bottom of the cable clamp; the upper 
clamp plate and the lower clamp plate are connected to two ends of the middle plate respectively; a 
5 substrate clamping cavity is defined by a space enclosed by the upper clamp plate and the middle 
plate, and a cable clamping cavity is defined by a space enclosed by the lower clamp plate and the 
middle plate; one of the upper clamp plate and the middle plate comprises position limiting parts 
on two sides thereof respectively, and the position limiting parts extend along a direction towards 
another one of the upper clamp plate and the middle plate; said another one of the upper clamp 
10 plate and the middle plate is provided with an inverted hook extending towards said one of the 
upper clamp plate and the middle plate; the inverted hook and the position limiting parts clamp 
against two opposite surfaces of a substrate inserted into the substrate clamping cavity. The 
inverted hook and the position limiting parts are provided on opposite surfaces of the upper clamp 
plate and the middle plate respectively, such that when the substrate is inserted into the substrate 
15 clamping cavity, the inverted hook and the position limiting parts can limit the movement of the 
substrate along an insertion direction of the substrate into the substrate clamping cavity and along a 
direction perpendicular thereto respectively. This achieves relative fixation between the cable 
clamp and the substrate, providing substantial clamping force to prevent movement of the cable 
clamp relative to the substrate, and enhancing post-installation structural stability.  
20
DRAWINGS OF THE SPECIFICATION 
5 
9 
10 
14
13 \12 16 
FIG.1I
Patent WO-2004098801-A1 (WO)
Title: Appareil et procede pour le nettoyage de catheters et d'autres dispositifs hemodynamiques
Inventor: TOSHI-ICHI TACHIBANA
IPC: A61M25/00
Filed: 2004-05-10
Abstract: Cette invention se rapporte à un appareil et à un procédé servant au nettoyage de cathéters et d'autres dispositifs hémodynamiques et comprenant à cet effet une première valve (12) destinée à commander l'injection d'eau, une seconde valve (17) destinée à commander l'évacuation d'eau, une pompe d'aspiration (19), un moyen de couplage (13, 14) raccordé à un cathéter terminé par un ballonnet à cycle fermé (15) ou à un autre dispositif hémodynamique similaire, un moyen de minutage (22) et un dispositif à mouvement alternatif (23). Le procédé d'utilisation de cette appareil comprend plusieurs cycles de lavage, qui sont constitués chacun par une première période (t1-t2), pendant laquelle de l'eau purifiée est introduite par pression positive, et par une seconde période (t2-t3), pendant laquelle l'eau de lavage est évacuée par pression négative, cette première période (t1-t2) étant sensiblement plus longue que la seconde période (t2-t3) et la pression négative assurant l'évacuation étant approximativement égale à 0,4 atmosphères.
Patent WO-2008080200-A1 (WO)
Inventor: KERKIS IRINA
IPC: C12N5/0775
Filed: 2006-12-29
Abstract: THE PRESENT INVENTION REFERS TO A PROCESS FOR OBTAINMENT OF ADULT STEM CELLS, PRESENTING CHARACTERISTICS OF EMBRYONIC STEM CELLS, FROM POSTNATAL AND ADULT TISSUES; TO ADULT STEM CELLS THAT PRESENT CHARACTERISTICS OF EMBRYONIC STEM CELLS; TO AN ADVANTAGEOUS PROCESS IN THE DIFFERENTIATION OF STEM CELLS AND, TO DIFFERENTIATED CELLS OBTAINED FROM SAID PROCESS. THE PRESENT INVENTION ALSO REFERS TO THE NUMEROUS POSSIBILITIES OF APPLICATION OF SAID CELLS, WHETHER OR NOT DIFFERENTIATED: THERAPEUTIC AND NON-THERAPEUTIC, BIOTECHNOLOGICAL AND PHARMACEUTICAL, RESULTING FROM THE DEVELOPMENT ACHIEVED BY THE INVENTORS.
Patent WO-2012155222-A1 (WO)
Title: Sistema virtual de saúde com agendamento de consultas via internet e interação entre pacientes e módulos de saúde
Inventor: CANABRAVA SERGIO FELIX
IPC: G16H80/00
Filed: 2011-05-16
Abstract: O sistema virtual de saúde com agendamento de consultas via internet e interação entre pacientes e módulos de saúde que interliga através de uma rede social o sistema de saúde público, o sistema de saúde privado, os planos de saúde, os hospitais, os laboratórios, as clínicas, os profissionais de saúde e os pacientes, disponibilizando agendamentos de consultas e procedimentos para a área de saúde além de possibilitar a interação via sistema entre seus usuários. O Sistema será composto por módulos dentro de um banco de dados unificado com as seguintes unidades; Posto Virtual (1), Plano Virtual (2), Hospital Virtual (3), Laboratório Virtual (4), Farmácia Virtual (5) e Consultório Virtual (6). Neste Sistema, cada profissional de saúde é um Profissional Virtual (7) e cada paciente é um Paciente Virtual (8). Eles poderão se conectar com cada um dos módulos citados acima, além de agendar consultas e procedimentos via internet.
Patent WO-2016058063-A1 (WO)
Title: Máquina para estampagem contínua de chapas segmentadas
Inventor: ZANGHELINI MAURICIO
IPC: B21D28/26
Filed: 2014-10-15
Abstract: O presente invento consiste de uma máquina puncionadora que permite a estampagem em chapas metálicas segmentadas de forma contínua. Dessa forma, pode-se fazer uma mesma ranhura em mais de um segmento, ou seja, iniciar a ranhura em um segmento e terminar em outro. O cabeçote de estampagem pode ser posicionado automaticamente comandado por um sistema computadorizado.
Patent WO-2004077960-A1 (WO)
Title: Emploi d'enzymes proteolytiques permettant de mieux exploiter l'alimentation chez des ruminants
Inventor: BEAUCHEMIN KAREN A
IPC: A23K1/165
Filed: 2004-02-13
Abstract: L'invention concerne un procédé permettant d'accroître la digestion de fibres chez des ruminants au moyen d'un additif alimentaire ou d'une composition alimentaire renfermant au moins une protéase. Spécifiquement, cette invention concerne un procédé propre à améliorer la digestibilité du fourrage ou d'une alimentation à base de grains, qui comprend au moins une protéase, et qui consiste à : donner un fourrage ou une nourriture à base de grains à un ruminant, appliquer la protéase sur le fourrage ou la nourriture à base de grain ; et à administrer la composition à l'animal, de manière à obtenir une amélioration de la digestibilité. L'invention concerne en outre des additifs alimentaires et des compositions alimentaires renfermant des protéases, des préparations contenant lesdits additifs ou compostions, et leurs utilisations.